LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2
Hongju Yang, Qian Li, Leisheng Zhang, Mei Zhu, Jie Niu, Fenglin Xue, Lihong Yang, Qiu Qu, Yaling Lao, Zheng Ding, Changyan Xiao, Kunhua Wang
Topics & Concepts
BiomarkerHematologyDiseaseFatty liverDiagnostic biomarkerMedicineInternal medicineComputational biologyBioinformaticsBiologyGeneticsLiver Disease Diagnosis and TreatmentCancer-related molecular mechanisms researchLipid metabolism and disorders